2023 Q4 Form 10-Q Financial Statement

#000149315223041141 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $246.6K $113.0K
YoY Change -24.07% -73.55%
Cost Of Revenue $129.6K $128.9K
YoY Change -3.84% -30.12%
Gross Profit $117.0K -$15.93K
YoY Change -38.41% -106.56%
Gross Profit Margin 47.45% -14.1%
Selling, General & Admin $443.1K $363.0K
YoY Change 24.05% -38.9%
% of Gross Profit 378.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $51.88K $23.75K
YoY Change 15.39% -53.21%
% of Gross Profit 44.34%
Operating Expenses $495.0K $515.7K
YoY Change 23.09% -37.82%
Operating Profit -$378.0K -$402.7K
YoY Change 78.16% 0.15%
Interest Expense $20.36K $626.1K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net $626.1K
YoY Change 5703.23%
Pretax Income -$3.238M $223.4K
YoY Change 1588.45% -157.09%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.238M $223.4K
YoY Change 1588.45% -157.09%
Net Earnings / Revenue -1313.13% 197.68%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share -$0.30 $0.02
COMMON SHARES
Basic Shares Outstanding 10.91M shares 10.91M shares
Diluted Shares Outstanding 10.95M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.059M $4.456M
YoY Change -10.73% 14.37%
Cash & Equivalents $4.059M $4.456M
Short-Term Investments
Other Short-Term Assets $35.24K $101.9K
YoY Change -58.32% -5.17%
Inventory
Prepaid Expenses
Receivables $71.74K $350.8K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.166M $4.909M
YoY Change -13.14% 16.26%
LONG-TERM ASSETS
Property, Plant & Equipment $1.559M $4.491M
YoY Change -66.23% -3.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.505M $4.390M
YoY Change 114.32% 254.95%
Other Assets $3.167K $3.167K
YoY Change 0.0% 0.0%
Total Long-Term Assets $6.213M $9.047M
YoY Change -10.41% 47.61%
TOTAL ASSETS
Total Short-Term Assets $4.166M $4.909M
Total Long-Term Assets $6.213M $9.047M
Total Assets $10.38M $13.96M
YoY Change -11.53% 34.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $156.6K $504.0K
YoY Change 37.66% 613.24%
Accrued Expenses $17.08K $17.08K
YoY Change 6.54% 6.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $248.9K $593.8K
YoY Change 27.55% 296.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $134.2K $152.9K
YoY Change -38.78% -35.09%
Total Long-Term Liabilities $134.2K $152.9K
YoY Change -38.78% -35.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $248.9K $593.8K
Total Long-Term Liabilities $134.2K $152.9K
Total Liabilities $383.1K $746.7K
YoY Change -7.53% 93.74%
SHAREHOLDERS EQUITY
Retained Earnings -$77.00M -$74.00M
YoY Change 4.35% 0.55%
Common Stock $10.91K $10.91K
YoY Change 5.61% 9.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.996M $13.21M
YoY Change
Total Liabilities & Shareholders Equity $10.38M $13.96M
YoY Change -11.53% 34.82%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$3.238M $223.4K
YoY Change 1588.45% -157.09%
Depreciation, Depletion And Amortization $51.88K $23.75K
YoY Change 15.39% -53.21%
Cash From Operating Activities $51.73K $428.9K
YoY Change -298.5% -347.16%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$448.7K -$1.506M
YoY Change -48.14% 182.54%
Cash From Investing Activities -$448.7K -$1.506M
YoY Change -48.19% 182.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 2.000K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 51.73K 428.9K
Cash From Investing Activities -448.7K -1.506M
Cash From Financing Activities 0.000 2.000K
Net Change In Cash -397.0K -1.077M
YoY Change -160.99% 52.41%
FREE CASH FLOW
Cash From Operating Activities $51.73K $428.9K
Capital Expenditures $0.00 $0.00
Free Cash Flow $51.73K $428.9K
YoY Change -291.95% -347.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001156041
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
usd
HUSA Changes In Accrued Equity Investment Contributions And Distributions
ChangesInAccruedEquityInvestmentContributionsAndDistributions
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Grants In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriodExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercised In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedInPeriodExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Forfeited Or Expired In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionForfeitedOrExpiredInPeriodExercisePrice
CY2023Q3 HUSA Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Warrant Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWarrantIntrinsicValue
usd
CY2023Q3 HUSA Sharebased Compensation Arrangement By Sharebased Payment Award Options Warrants Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWarrantsExercisableIntrinsicValue1
usd
CY2023Q3 HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
CY2022Q3 HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
HUSA Effect Of Common Stock Equivalents
EffectOfCommonStockEquivalents
usd
HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-32955
dei Entity Registrant Name
EntityRegistrantName
HOUSTON AMERICAN ENERGY CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0675953
dei Entity Address Address Line1
EntityAddressAddressLine1
801 Travis Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1425
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
dei City Area Code
CityAreaCode
(713)
dei Local Phone Number
LocalPhoneNumber
222-6966
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
HUSA
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10906353 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4456158 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4547210 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
350764 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164575 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
101845 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
84544 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
4908767 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4796329 usd
CY2023Q3 HUSA Costs Subject To Amortization
CostsSubjectToAmortization
62775441 usd
CY2022Q4 HUSA Costs Subject To Amortization
CostsSubjectToAmortization
62786267 usd
CY2023Q3 HUSA Costs Not Being Amortized
CostsNotBeingAmortized
2343126 usd
CY2022Q4 HUSA Costs Not Being Amortized
CostsNotBeingAmortized
2343126 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
90004 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
90004 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65208571 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65219397 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60717696 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60602051 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4490875 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4617346 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
4390467 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2102139 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162444 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
212202 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3167 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3167 usd
CY2023Q3 us-gaap Assets
Assets
13955720 usd
CY2022Q4 us-gaap Assets
Assets
11731183 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
504024 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
113741 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17083 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16035 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72691 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65385 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
593798 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
195161 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90940 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
146359 usd
CY2023Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
61964 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
72789 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
152904 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
219148 usd
CY2023Q3 us-gaap Liabilities
Liabilities
746702 usd
CY2022Q4 us-gaap Liabilities
Liabilities
414309 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10906353 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10906353 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10327646 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10327646 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
10907 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10328 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86958669 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85094266 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73760558 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73787720 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
13209018 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11316874 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13955720 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11731183 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112994 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
427256 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
547408 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1314065 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
128918 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
184488 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
344318 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
496245 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
363011 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
594081 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1409445 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1223077 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23749 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50755 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
115645 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
160495 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
515678 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
829324 usd
us-gaap Operating Expenses
OperatingExpenses
1869408 usd
us-gaap Operating Expenses
OperatingExpenses
1879817 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-402684 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-402068 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1322000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-565752 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
39426 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
10788 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
114061 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
13277 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
586626 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1235101 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
626052 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10788 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1349162 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13277 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
223368 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-391280 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27162 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-552475 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
223368 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391280 usd
us-gaap Net Income Loss
NetIncomeLoss
27162 usd
us-gaap Net Income Loss
NetIncomeLoss
-552475 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10906353 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9928338 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10742407 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9928338 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10949956 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10379291 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10946991 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9928338 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11316874 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
84445 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
901500 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
104175 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12406994 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77870 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
750500 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-300381 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12934983 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50667 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
223368 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
13209018 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10311943 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85485 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-165560 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10231868 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25520 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4365 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10261753 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10261753 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
95205 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391280 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391280 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9965678 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9965678 usd
us-gaap Net Income Loss
NetIncomeLoss
27162 usd
us-gaap Net Income Loss
NetIncomeLoss
-552475 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
115645 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
160495 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
2336 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
3697 usd
us-gaap Share Based Compensation
ShareBasedCompensation
212982 usd
us-gaap Share Based Compensation
ShareBasedCompensation
206210 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
49758 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
45237 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-125355 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3870 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
311544 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34659 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21997 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
72541 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1939 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-48113 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-42136 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
211463 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-202900 usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
14160 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1954515 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
781155 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1954515 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-795315 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1652000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1652000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-91052 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-988215 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4547210 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4894578 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4456158 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3896362 usd
us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
10826 usd
HUSA Changes In Accrued Equity Investment Contributions And Distributions
ChangesInAccruedEquityInvestmentContributionsAndDistributions
333813 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zURQvOVlEaxl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zBGk0vTP4sbi">Accounting Principles and Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. In preparing financial statements, management makes informed judgments and estimates that affect the reported amounts of assets and liabilities as of the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management reviews its estimates, including those related to such potential matters as litigation, environmental liabilities, income taxes and the related valuation allowance, determination of proved reserves of oil and gas and asset retirement obligations. Changes in facts and circumstances may result in revised estimates and actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zqDfGzxRZq15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zexgMLKUV0V6">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to a concentration of credit risk include cash, cash equivalents and any marketable securities (if any). The Company had cash deposits of $<span id="xdx_90F_eus-gaap--Deposits_iI_pn5n6_c20230930_zV49GgCee7X2" title="Cash deposits">4.2</span> million in excess of the FDIC’s current insured limit on interest bearing accounts of $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230930_zxw6lIOaDQ92" title="Cash FDIC insured amount">250,000</span> as of September 30, 2023. The Company also had cash deposits of $<span id="xdx_900_eus-gaap--Deposits_iI_pp0p0_c20230930__us-gaap--CreditFacilityAxis__custom--ColombianBankMember_z6Bkbdh4ex3d" title="Cash deposits">3,882</span> in Colombian banks at September 30, 2023 that are not insured by the FDIC. The Company has not experienced any losses on its deposits of cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Deposits
Deposits
4200000 usd
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112994 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
427256 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
547408 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1314065 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q3 us-gaap Depletion
Depletion
23749 usd
us-gaap Depletion
Depletion
115645 usd
CY2022Q3 us-gaap Depletion
Depletion
50755 usd
us-gaap Depletion
Depletion
160495 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
547408 usd
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
4490875 usd
us-gaap Costs Incurred Acquisition Of Oil And Gas Properties
CostsIncurredAcquisitionOfOilAndGasProperties
2288328 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
1235101 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
944177 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
60000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
3370 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.85
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1000807 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.46
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
190520 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
955481 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.47
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
190520 usd
us-gaap Share Based Compensation
ShareBasedCompensation
212982 usd
us-gaap Share Based Compensation
ShareBasedCompensation
206210 usd
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Basic
EarningsPerShareEffectOfShareBasedCompensationExpenseBasic
-0.02
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Diluted
EarningsPerShareEffectOfShareBasedCompensationExpenseDiluted
-0.02
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Basic
EarningsPerShareEffectOfShareBasedCompensationExpenseBasic
-0.01
HUSA Earnings Per Share Effect Of Share Based Compensation Expense Diluted
EarningsPerShareEffectOfShareBasedCompensationExpenseDiluted
-0.01
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
94400 shares
CY2022Q4 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Exercise Price Rage Number Of Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare
2.46
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
94400 shares
CY2023Q3 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Exercise Price Rage Number Of Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare
2.46
CY2023Q3 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
94400 shares
CY2023Q3 HUSA Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisableWeightedAverageExercisePrice
2.46 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
223368 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-391280 usd
us-gaap Net Income Loss
NetIncomeLoss
27162 usd
us-gaap Net Income Loss
NetIncomeLoss
-552475 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
223368 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-391280 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
27162 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-552475 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10906353 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9928338 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10742407 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9928338 shares
CY2023Q3 HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
43603 shares
CY2022Q3 HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
455953 shares
HUSA Dilutive Effect Of Common Stock Equivalents Options And Warrants
DilutiveEffectOfCommonStockEquivalentsOptionsAndWarrants
204584 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10949956 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10379291 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10946991 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9928338 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
579881 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1093877 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
473481 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1093877 shares
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
22011 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
88801 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
75051 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
185863 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22232 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
163631 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72691 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90940 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162444 usd
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
22161 usd
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
19647 usd
us-gaap Payments For Rent
PaymentsForRent
66483 usd
us-gaap Payments For Rent
PaymentsForRent
58837 usd

Files In Submission

Name View Source Status
husa-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-23-041141-index-headers.html Edgar Link pending
0001493152-23-041141-index.html Edgar Link pending
husa-20230930_lab.xml Edgar Link unprocessable
husa-20230930_cal.xml Edgar Link unprocessable
0001493152-23-041141.txt Edgar Link pending
0001493152-23-041141-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
husa-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
husa-20230930_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed